Financing, Equity Capital Markets

Sagimet Biosciences

07/23
|
$85.0 Million
Sagimet
Piper Sandler served as bookrunner for Sagimet Biosciences, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma